DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology reported Q2 FY27 revenue of $3.03 billion, down 4.0% year over year, and non-GAAP diluted EPS of $0.67, down 20.2%; adjusted EBIT margin fell to 6.2% from 8.0%. First-half free cash flow improved to $405 million from $337 million, while quarterly bookings declined 10% to $2.4 billion. FY27 guidance calls for organic revenue to decline 5.0%–5.5%, adjusted EBIT margin of 5.75%–6.25%, and non-GAAP EPS of $2.25–$2.50; the company also repurchased $60 million of shares and acknowledged discussions about a possible sale of its insurance business.

Analysis

The key issue is deterioration in the legacy engine, not whether AI becomes a growth story. GIS’s revenue and profit declines, alongside quarterly bookings below replacement, point to a risk that contract runoff and weak new wins pressure revenue and utilization over the next several quarters. CES bookings also weakened, so the problem is broader than infrastructure alone. AI could eventually improve delivery economics, but automation may also reduce labor-based contract revenue before DXC captures enough higher-value AI work; management’s deal commentary is not yet evidence of material revenue or margin contribution.

Insurance is the counterweight, but its reported acceleration includes a favorable contract modification and the company is discussing a possible sale. A transaction could provide cash for debt reduction, yet would also remove the fastest-growing segment and leave investors with greater exposure to shrinking core services. Treat any sale premium as conditional until terms, retained economics, and use of proceeds are clear. The first-half free-cash-flow comparison is also flattered by a litigation award in reported results; underlying operating momentum deserves more weight than headline cash generation.

Near term, an above-expectations quarter may support a relief reaction, but Q3 guidance implies further revenue pressure. Over 1–3 months, watch bookings conversion, GIS margin, and sale disclosures. Over 6–18 months, the thesis turns on whether AI work offsets legacy runoff. The contrarian risk to a bearish view is that mission-critical work and restructuring stabilize margins before revenue inflects.

Key Decisions for Investors

• Prefer a small relative-value short in DXC versus a long in Accenture, entered on a post-call relief rally rather than chasing an immediate drop. The thesis is weaker bookings and core-services deterioration; avoid assigning a numeric target without valuation and market-price context.
• Do not underwrite the Insurance business’s growth as durable or include sale proceeds in base-case value until DXC discloses transaction terms, recurring versus one-time revenue contribution, and intended use of proceeds. A sale that funds material debt reduction without a large earnings give-up would weaken the short case.
• Reassess if bookings recover above replacement and GIS revenue and segment margin stabilize, or if management demonstrates repeatable AI revenue with measurable follow-on conversion. Continued sub-1.0x quarterly book-to-bill, further GIS margin erosion, or a downward revision to FY guidance would strengthen the bearish thesis.